Review: Retraction notice: Cardiovascular disease, drug therapy, and mortality in COVID-19

Review: Retraction notice: Cardiovascular disease, drug therapy, and mortality in COVID-19

A retraction notice was published regarding the study titled: “Cardiovascular disease, drug therapy, and mortality in COVID-19,” which appeared in The New England Journal of Medicine on May 1st. 

  • Because of concerns that arose from a separate study concerning data from Surgisphere, the authors launched an independent third-party peer review of the full data set
  • Surgisphere refused to transfer the full data set, leading to their withdrawal of the paper
  • The authors also used Surgisphere for a data set published in The Lancet, which is also being retracted
|2020-06-05T11:24:15-04:00June 4th, 2020|COVID-19 Literature|Comments Off on Review: Retraction notice: Cardiovascular disease, drug therapy, and mortality in COVID-19

About the Author: CTSI Author

CTSI Author

Get Involved with Indiana CTSI